Join our webinar on July 25th for an introduction and background on humanized mouse models, focusing on their effective applications in preclinical research for advancing targeted therapies across diseases.
Date:
- Thursday, July 25th, 2024; 2:00 pm EDT or 11:00 am PDT
Webinar Highlights:
- Introduction to humanized mouse models for preclinical research developed by GenoBioTX
- Discover examples of how humanized mouse models have accelerated preclinical therapeutic advancements
- Further explore the generation of humanized immune system models for targeted oncology drug development
Meet Our Speaker:
Dr. Derek Reznik earned his Ph.D. in Neuroscience from Baylor College of Medicine where he leveraged novel animal models to discover biomarkers and isolate preclinical readouts with greater translational potential toward the goal of bridging the gap between preclinical research and effective therapeutics for desperate patients and their caregiving communities. Dr. Reznik is an expert in the preclinical modeling of disease in both genetically engineered mice and rat models. In early 2024, he brought his preclinical expertise to GenoBioTX as a Business Development Manager within the Industrial Clients Department.
About GenoBioTX
GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.
